Literature DB >> 25302164

Surgical strategies in the therapy of non-small cell lung cancer.

Feras Al-Shahrabani1, Daniel Vallböhmer1, Sebastian Angenendt1, Wolfram T Knoefel1.   

Abstract

Lung cancer represents the leading cause of cancer mortality worldwide. Despite improvements in preoperative staging, surgical techniques, neoadjuvant/adjuvant options and postoperative care, there are still major difficulties in significantly improving survival, especially in locally advanced non-small cell lung cancer (NSCLC). To date, surgical resection is the primary mode of treatment for stage I and II NSCLC and has become an important component of the multimodality therapy of even more advanced disease with a curative intention. In fact, in NSCLC patients with solitary distant metastases, surgical interventions have been discussed in the last years. Accordingly, this review displays the recent surgical strategies implemented in the therapy of NSCLC patients.

Entities:  

Keywords:  Multimodality therapy; Neoadjuvant/adjuvant therapy; Non-small cell lung cancer; Solitary distant metastases; Surgical techniques

Year:  2014        PMID: 25302164      PMCID: PMC4129525          DOI: 10.5306/wjco.v5.i4.595

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  90 in total

Review 1.  Non-small cell lung cancer.

Authors:  David S Ettinger; Wallace Akerley; Gerold Bepler; Matthew G Blum; Andrew Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Thierry Jahan; Mohammad Jahanzeb; David H Johnson; Anne Kessinger; Ritsuko Komaki; Feng-Ming Kong; Mark G Kris; Lee M Krug; Quynh-Thu Le; Inga T Lennes; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; George R Simon; Scott J Swanson; Douglas E Wood; Stephen C Yang
Journal:  J Natl Compr Canc Netw       Date:  2010-07       Impact factor: 11.908

Review 2.  Preoperative evaluation of the lung resection candidate.

Authors:  Peter Mazzone
Journal:  Cleve Clin J Med       Date:  2012-05       Impact factor: 2.321

3.  Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies.

Authors:  Christophe Doddoli; Benoit D'Journo; Françoise Le Pimpec-Barthes; Antoine Dujon; Christophe Foucault; Pascal Thomas; Marc Riquet
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

4.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

5.  Avoidable cancer deaths globally.

Authors:  Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

6.  A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.

Authors:  Yi long Wu; Zhi-fan Huang; Si-yu Wang; Xue-ning Yang; Wei Ou
Journal:  Lung Cancer       Date:  2002-04       Impact factor: 5.705

Review 7.  Chest wall resection for lung cancer: indications and techniques.

Authors:  Erich Stoelben; Corinna Ludwig
Journal:  Eur J Cardiothorac Surg       Date:  2009-02-01       Impact factor: 4.191

8.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

Review 9.  Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysis.

Authors:  Zhiyuan Ma; Aiqiang Dong; Junqiang Fan; Haifeng Cheng
Journal:  Eur J Cardiothorac Surg       Date:  2007-04-17       Impact factor: 4.191

10.  Thoracoscopic versus open lobectomy debate: the pro argument.

Authors:  Frank Detterbeck
Journal:  Thorac Surg Sci       Date:  2009-08-03
View more
  6 in total

1.  Japonicone A inhibits the growth of non-small cell lung cancer cells via mitochondria-mediated pathways.

Authors:  Yan Du; Jiannan Gong; Xinrui Tian; Xiaomei Yan; Tao Guo; Min Huang; Bingtai Zhang; Xiaoyun Hu; Hui Liu; Yinping Wang; Jianqiang Li; Maolan Li
Journal:  Tumour Biol       Date:  2015-04-25

2.  Activation of Toll-like receptors signaling in non-small cell lung cancer cell line induced by tumor-associated macrophages.

Authors:  Xing Ke; Meng Wu; Jianfang Lou; Shuping Zhang; Peijun Huang; Ruihong Sun; Lei Huang; Erfu Xie; Fang Wang; Bing Gu
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

3.  New PET/CT criterion for nodal staging in non-small cell lung cancer: measurement of the ratio of section area of standard uptake values ≥2.5/lymph node section area.

Authors:  Yoshitaro Saito; Kazuhiro Imai; Koichi Ishiyama; Hajime Saito; Satoru Motoyama; Yusuke Sato; Hayato Konno; Satoshi Fujishima; Manabu Hashimoto; Yoshihiro Minamiya
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-23

4.  Targeted percutaneous microwave ablation at the pulmonary lesion combined with mediastinal radiotherapy with or without concurrent chemotherapy in locally advanced non-small cell lung cancer evaluation in a randomized comparison study.

Authors:  Xinglu Xu; Xin Ye; Gang Liu; Tingping Zhang
Journal:  Med Oncol       Date:  2015-08-05       Impact factor: 3.064

Review 5.  Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

Authors:  Percy Lee; Billy W Loo; Tithi Biswas; George X Ding; Issam M El Naqa; Andrew Jackson; Feng-Ming Kong; Tamara LaCouture; Moyed Miften; Timothy Solberg; Wolfgang A Tome; An Tai; Ellen Yorke; X Allen Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-05       Impact factor: 8.013

6.  miR-195-5p Suppresses Lung Cancer Cell Proliferation, Migration, and Invasion Via FOXK1.

Authors:  Zhiqiang Long; Yadong Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.